Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... Our HGT pipeline has been strengthened by positive results from our trial of velaglucerase in naïve ... GSK for adult ADHD. We are also expecting further positive newsflow from our pipeline during the second half ... in 2008. These factors more than offset the positive impacts of price increases taken since Q2 2008, ...New Report Just Published: World Prostate Cancer Therapeutics Market Report
... Cancer II-53 Isis and OncoGenex Reveals positive results of OGX-011 Molecule in HRPC II-53 ... Immunotherapy II-59 Spectrum Announces positive Outcome of Satraplatin Trial on HRPC Patients ... Phase I Study for Prostate Cancer II-61 positive Results of Combined Hormone and Radiation ...Biotech Shows Glimmer of an Upward Trend
... 1 /PRNewswire/ -- The markets closed out May in positive territory following on from their April ... Nasdaq close behind - up 3.3 percent in May. The positive market trend helped biotech with the Burrill ... percent since the company first announced it had positive Phase III data that showed its lead product ...Arena Pharmaceuticals Announces First Quarter 2009 Financial Results
... million, or $0.75 per share. "Receiving the positive lorcaserin BLOOM results was a significant ... Announced positive top-line results from BLOOM. Lorcaserin was ... Announced the completion of a positive randomized, double-blind, placebo-controlled ...NeurogesX Reports First Quarter 2009 Results
... Corporate Highlights: - CHMP issued positive opinion recommending approval of Qutenza(TM) ... of the European Medicines Agency (EMEA) issued a positive opinion recommending approval of the marketing ... non-diabetic adults in the E.U. The CHMP's positive opinion recommending E.U. approval of Qutenza for ...Oncolytics Biotech(R) Inc. Announces 2009 First Quarter Results
... 2009 was highlighted by the announcement of very positive results in several of our combination REOLYSIN(R) ... First Quarter Highlights: - Announced positive interim results from a U.K. Phase I/II ... stable disease) of 75%; - Announced positive results from a U.K. combination REOLYSIN and ...NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
... application (MAA) for Qutenza received a positive opinion from the Committee for Medicinal Products ... application (MAA) for Qutenza received a positive opinion from the Committee for Medicinal Products ... and uncertainties, including, but not limited to; positive results in clinical trials may not be sufficient ...Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments
... 31, up $24 million from year-end 2008 - - positive results for second Phase 3 trial of Albuferon ... and Chief Executive Officer. "We reported positive results from the second of two pivotal trials of ... of Health and Human Services (HHS). positive Results Announced for Second of Two Phase 3 ...NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
... Products for Human Use (CHMP) has issued a positive opinion recommending approval of Qutenza(TM) ... from peripheral neuropathic pain. The CHMP's positive recommendation will be evaluated by the European ... President and CEO, commented, "The CHMP's positive recommendation for approval of Qutenza in the ...ThromboGenics Announces Business Update and 2008 Full Year Results
... to start the Phase III program was based on the positive Phase II clinical results which were announced ... Highlights Microplasmin - Eye Disease: positive results announced in Phase II clinical trials for back of the eye indications. positive results were reported in ThromboGenics' Phase IIb ...Microbix First Quarter Sales Grow Over 50% With Continued Progress On The Pipeline
... for the first quarter 2009 compared to cash flow positive in fiscal 2008. The loss for the quarter was ... would be accretive to the Company's projected positive cash flows. ... commercial development. The Company was cash flow positive $5,603,173, in the same period in 2008 due to an ...BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update
... Officer of BioCryst. "We were pleased to report positive data, from both our internal and partnered ... Shionogi initiated this Phase 3 study based on positive clinical results from a Phase 2 study that ... preclinical and clinical development may not have positive results, that we or our licensees may not be able ...AdvanDx Receives FDA 510(k) Clearance for E. coli/P. aeruginosa PNA FISH(R)
... E. coli and P. aeruginosa Directly from positive Blood Cultures PNA FISH to Provide Critical ... and/or Pseudomonas aeruginosa directly from positive blood cultures. E. coli / P. aeruginosa PNA ... E. coli and P. aeruginosa directly from positive blood cultures and the latest addition to ...A supercharged metal-ion generator
... gun, which uses energetic ions atoms with a positive charge to knock the metal atoms off a target. ... rate between atoms and electrons to create more positive ions that can be accelerated toward the target. ... more than ten times greater than the current of positive ions that actually reaches the substrate. But ...Amylin Pharmaceuticals Highlights 2009 Value Creation Opportunities
... and position the Company to be cash flow positive by the end of 2010. The news was presented by ... and make significant progress toward achieving positive operating cash flow by the end of 2010 ... unwavering focus on managing expenses to achieve positive cash flow by the end of 2010." A recording ...BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
... of BioSpecifics. "In 2008, we announced positive Phase 3 clinical results for our collagenase ... agreement with Auxilium Pharmaceuticals, Inc. positive top line results from the Phase III clinical ... were released in June 2008. Based on those positive Phase III results, Auxilium expects to file a ...NicOx Signs Agreement With DSM for the Commercial Manufacture of Naproxcinod Drug Substance
... agents, which recently achieved positive results in the third pivotal phase 3 study in ... and Operations at NicOx, commented: "The latest positive results observed in the 111 and 303 studies ... co-primary efficacy endpoints. Following the positive results from the 301 and 302 studies in ...BioMS Medical Announces Third Quarter 2008 Results
... Europe and the U.S. "The third quarter saw positive developments in the dirucotide development plan, ... 9 countries. To date, there have been nine positive safety reviews from the Data Safety ... payment and development milestone for the positive interim analysis related to the MAESTRO-01 ...ev3 Inc. Reports Third Quarter 2008 Financial Results
... DEFINITIVE clinical trial strategy could have a positive impact on sales and procedure adoption." ev3's ... and NanoCross PTA balloons; -- Reported positive 12-month follow-up results for the ... Changes in foreign currency exchange rates had a positive impact of approximately $1.7 million on third ...Genetic clock makers at UC San Diego publish their 'timepiece' in Nature
... proteins are made. On top of this is the positive feedback loop which makes the clock more regular ... the negative feedback loop is at the core and the positive feedback is the icing on top," said Matthew ... of primitive negative feedback loop, with the positive loop coming later to regularize it," said Hasty. ...AdvanDx Receives FDA 510(k) Clearance for Yeast Traffic Light PNA FISH(TM)
... Identify Five Candida Species Directly From positive Blood Cultures In One Test WOBURN, Mass., Sept. ... to identify Candida yeast species directly from positive blood cultures. The Yeast Traffic Light(TM) is ... test, up to five Candida species directly from positive blood cultures including C. albicans and/or C. ...MIGENIX Reports First Quarter Fiscal 2009 Financial Results
... 2008 to the first quarter of calendar 2009. With positive results in the CLIRS trial, Cadence continues to ... being developed for the treatment of serious gram positive bacterial infections, including highly publicized ... and preclinical), the treatment of serious gram positive bacterial infections (preclinical) and the ...Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2009
... cancer program and reporting encouraging positive data from the trial testing bavituximab in ... cancer program are now underway: -- Reported positive early results from the first cohort of ... with non-small cell lung cancer. -- Presented positive data from a completed Phase I study ...ThromboGenics Announces Half Year Results 2008
... tissues. Clinical Highlights - TB-403 : positive results announced in first Phase Ia study with ... patients with advanced cancer. - Microplasmin: positive results announced in Phase II clinical trials for ophthalmic indications. positive results were reported in ThromboGenics' Phase ...